Nalbuphine and Flurbiprofen for Oculoplastic Surgery

• Status: Completed
• Trial end date: 2018-09-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the postoperative pain and discomfort using flurbiprofen axetil or nalbuphine administration after oculoplastic surgery under general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sun Yat-sen University
• Treatments: Flurbiprofen; Flurbiprofen axetil; Nalbuphine

Criteria

Inclusion Criteria:

• Undergoing oculoplastic surgery

• age between 16 and 75 years

• American Society of Anesthesiologists (ASA) physical status of I-II

Exclusion Criteria:

• serious coexisting disease

• body mass index (BMI) <18.5 or >35

• contraindications or previous adverse reactions to any of the drugs used

• females with a positive pregnancy test

• patients unable to cooperate